NCT05292664 2026-03-12Venetoclax Basket Trial for High Risk Hematologic MalignanciesDana-Farber Cancer InstitutePhase 1 Recruiting30 enrolled
NCT03465540 2023-04-12Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesAmgenPhase 1 Terminated24 enrolled 21 charts